Development and external validation of nomograms for predicting prostate cancer and clinically significant prostate cancer in patients with PSA between 4 and 20 ng/mL.

ABSTRACT:

SUBMITTER: Wu K 

PROVIDER: S-EPMC12911229 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature